Serial Number 79394721
Registration 7830548
700

Registration Progress

Application Filed
Apr 2, 2024
Under Examination
Approved for Publication
Apr 29, 2025
Published for Opposition
Apr 29, 2025
Registered
Jun 17, 2025

Trademark Image

Basic Information

Serial Number
79394721
Registration Number
7830548
Filing Date
April 2, 2024
Registration Date
June 17, 2025
Published for Opposition
April 29, 2025
Drawing Code
2

Status Summary

Current Status
Active
Status Code
700
Status Date
Jun 17, 2025
Registration
Registered
Classes
005 035 042

Rights Holder

Percheron Therapeutics Limited

83
Address
Level 30, 35 Collins Street
Melbourne VIC 3000
AU

Ownership History

Percheron Therapeutics Limited

Original Applicant
83
AU

Percheron Therapeutics Limited

Owner at Publication
83
AU

Percheron Therapeutics Limited

Original Registrant
83
AU

Legal Representation

Attorney
Frederick H. Colen

USPTO Deadlines

Next Deadline
1988 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20250617)
Due Date
June 17, 2031
Grace Period Ends
December 17, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

27 events
Date Code Type Description Documents
Oct 30, 2025 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Oct 24, 2025 OPNX P NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Loading...
Oct 2, 2025 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Oct 2, 2025 OPNR P NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Loading...
Sep 25, 2025 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Sep 17, 2025 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Jun 17, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jun 17, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Apr 29, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 29, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 23, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 31, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 24, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Mar 24, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Mar 24, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Mar 21, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 21, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 21, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Oct 12, 2024 RFNT P REFUSAL PROCESSED BY IB Loading...
Sep 25, 2024 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Sep 24, 2024 RFRR P REFUSAL PROCESSED BY MPU Loading...
Sep 22, 2024 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Sep 21, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 18, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
May 13, 2024 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
May 13, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 2, 2024 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of rare neurological diseases and cancer
Class 035
Business intermediary services relating to the commercializing of goods, namely, negotiation of commercial transactions for third parties
Class 042
Scientific research in the nature of conducting clinical trials for others; medical and scientific research, namely, conducting clinical trials for others; biotechnology research, namely, biotechnology testing; scientific research relating to pharmaceuticals; pharmaceutical research services; services for assessing the efficiency of pharmaceuticals, namely, testing of pharmaceuticals; services for assessing the safety of pharmaceuticals, namely, testing of pharmaceuticals

Additional Information

Design Mark
The mark consists of a design of a stylized horse partially formed by wavy lines.

Classification

International Classes
005 035 042